Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1985-10-02
1987-10-27
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530324, A61K 3736, A61K 3743, C07K 710
Patent
active
047030356
ABSTRACT:
Surprisingly active fragments of human pancreatic GRF have been synthesized which exhibit good biological activity. These synthetic peptides are extremely potent in stimulating the release of pituitary GH in humans and in nonhuman animals and have the general formula: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser- Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Y wherein Y is NH.sub.2, Gln-NH.sub.2, Gln-Gln-NH.sub.2 or Gln-Gln-Gly-NH.sub.2. Two such fragments have been tested, namely the 29 and the 32 N-terminal residue sequences that are amidated at the C-terminus. These peptides, as well as nontoxic salts thereof, may be administered therapeutically to animals, including humans.
REFERENCES:
patent: 4517181 (1985-05-01), Ling et al.
patent: 4563352 (1986-01-01), Rivier et al.
Rivier Jean E. F.
Spiess Joachim
Vale, Jr. Wylie W.
Phillips Delbert R.
The Salk Institute for Biological Studies
LandOfFree
Human pancreatic GRF amidated fragments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human pancreatic GRF amidated fragments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human pancreatic GRF amidated fragments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1272319